Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Orforglipron

ATTAIN-1

Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 3127

NCT05869903

ArmPopulationDoseWeeksEstimandWeight change
PlaceboPopulation n/rn/rn/rn/rn/r
6 mg OrforglipronPopulation n/r6 mgn/rn/rn/r
12 mg OrforglipronPopulation n/r12 mgn/rn/rn/r
36 mg OrforglipronPopulation n/r36 mgn/rn/rn/r